ASTRA Therapeutics Seed Round Closing
ASTRA Therapeutics SA, a start-up company developing precision drugs against eukaryotic pathogens, announced the successful closing of its CHF 7.75m seed financing round.
The investment was co-led by MIG Capital and Digitalis...
GlycoEra AG closes Series-B-financing round
GlycoEra AG, a biotechnology company pioneering best-in-class extracellular protein degraders for the treatment of autoimmune diseases, announced the closing of an oversubscribed USD 130m Series-B-financing.
EraCal Therapeutics AG to license certain assets to Novo Nordisk
EraCal Therapeutics AG ("EraCal"), a Swiss biotech start-up company focusing on the fight of obesity has licensed certain assets to Novo Nordisk for a total amount of EUR 235m in a collaboration and license deal.
GlycoEra AG increases its Series A Financing Round with investment by BMS
GlycoEra AG in Wädenswil, has increased its Series A Financing Round with a substantial additional investment by Bristol Meyer Squibb (BMS).
Luciole Medical AG acquires Spiegelberg Group
Luciole Medical, a Swiss medical technology company specialized in brain monitoring, acquires Spiegelberg GmbH & Co. KG (Spiegelberg), an established medical device company and provider of highly specialized devices and consumables for neurosurgery, from SHS Capital.
Follow-On Offering of Oculis Holding AG
Oculis Holding AG (Nasdaq: OCS), a global biopharmaceutical company purposefully driven to save sight and improve eye care, has placed a follow-on public offering of 3.5m ordinary shares at a public offering price of USD 11.50 per ordinary share, for gross proceeds of USD 40.25m, before deducting underwriting discounts and commissions and offering expenses.
ImmunOs Therapeutics AG to raise CHF 74m Series B financing
ImmunOs Therapeutics AG has agreed to a CHF 74 million Series B financing led by incoming co-lead investors Samsara Biocapital, Lightspeed Venture Partners and Gimv, corner-stoned by GL Capital, Mission BioCapital, Peak 6 Strategic Capital and Fiscus Financial
Dubai's DP World and Swissterminal enter strategic partnership
DP World and Swissterminal, the leading container terminal operator in Switzerland, have entered a strategic partnership. DP World will take a stake of 44% in Swissterminal Holding AG with the Mayer family, the business' founder,...
Sale of the BASF Schweiz AG site in Klybeck / Basel
BASF Schweiz AG has sold its approximately 120,000 sqm stake in the Klybeck site in Basel to Swiss Life.
Dr. Thomas Gelzer and Dr. Francesca Pesenti were responsible for notarization and execution of this transaction.
Riemser invests in Anwerina
RIEMSER Arzneimittel AG invests in anwerina AG, a life science company specialized in the development and marketing of innovative orthopedic pharmaceutical and medical products.
VISCHER advises anwerina AG in the transaction. The...